-transparent.png){kind=logo}
Twenty-two patients with advanced or recurrent cancer of the cervix treated with cis-platinum, adriamycin and cyclophosphamide were evaluated. Nine of 22 (41% achieved objective response (2 CR + 7PR), 9/22 (41%) stable disease, 4/22 (18%) progressive disease. The mean duration of response was 24.6 weeks, with a range of 18-28 weeks. Patients with poorly differentiated histologic grade and without previous treatment had better response rates. Responders had longer survival (mean 63.5 + weeks) than nonresponders (mean 30.5 weeks). Commonly encountered toxicities were alopecia, nausea and vomiting, and leucopenia, which were all tolerable.
Related Publications
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
August 1983,
Gynecologic oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
February 1987,
Gynecologic oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
June 1985,
Gynecologic oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
September 1984,
British journal of obstetrics and gynaecology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
August 1988,
American journal of clinical oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
January 1983,
Cancer chemotherapy and pharmacology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
June 1985,
European journal of cancer & clinical oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
February 1981,
Cancer,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
January 1982,
Oncology,
A H Villalon, and
J Y Lu-Lim, and
D V Esteba, and
A Manalo, and
L Sotto, and
M V Jimenez, and
B M Agustin
January 1986,
Oncology,
